Cargando…

S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire?

S2.5 RARE YEASTS, SEPTEMBER 21, 2022, 3:00 PM - 4:30 PM: Candida auris (C. auris) is a recently emerged human fungal pathogen of growing concern due to its ability to acquire extensive multidrug resistance (MDR) to all four antifungal drug classes. The unprecedented extent of MDR in C. auris, sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Carolus, Hans, Sofras, Dimitrios, Sephton-Clark, Poppy, Goossens, Louise, Chen, Alicia, Pierson, Siebe, Romero, Celia Lobo, Subotić, Ana, Meis, Jacques F., Cuomo, Christina A., Van Dijck, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515916/
http://dx.doi.org/10.1093/mmy/myac072.S2.5d
_version_ 1784798597329453056
author Carolus, Hans
Sofras, Dimitrios
Sephton-Clark, Poppy
Goossens, Louise
Chen, Alicia
Pierson, Siebe
Romero, Celia Lobo
Subotić, Ana
Meis, Jacques F.
Cuomo, Christina A.
Van Dijck, Patrick
author_facet Carolus, Hans
Sofras, Dimitrios
Sephton-Clark, Poppy
Goossens, Louise
Chen, Alicia
Pierson, Siebe
Romero, Celia Lobo
Subotić, Ana
Meis, Jacques F.
Cuomo, Christina A.
Van Dijck, Patrick
author_sort Carolus, Hans
collection PubMed
description S2.5 RARE YEASTS, SEPTEMBER 21, 2022, 3:00 PM - 4:30 PM: Candida auris (C. auris) is a recently emerged human fungal pathogen of growing concern due to its ability to acquire extensive multidrug resistance (MDR) to all four antifungal drug classes. The unprecedented extent of MDR in C. auris, suggests accelerated resistance evolution, novel mechanisms of resistance, and/or potential fitness compensation. Despite being the first fungus to be officially considered an urgent antimicrobial resistance threat by the CDC (US), insights into the resistance mechanisms and evolutionary dynamics of C. auris are still scarce.  : By using high-throughput in vitro experimental evolution with various antifungal drugs, we have obtained a library of resistant strains from four different clades. Through both genome and targeted sequencing, we have discovered novel mutations, especially for polyene resistance, which indicate new mechanisms of resistance and fitness compensation. For the validation of mutations, we have optimized a recyclable CRISPR/Cas9 tool for C. auris based on the C. albicans HIS-FLP system.  : By mapping drug susceptibility responses of evolved strains across a library of several antifungals and repurposed drugs, we have discovered trends of cross-resistance and collateral sensitivity. Both phenomena have been extensively studied in tumors and bacteria but remain unexplored in fungi. In the light of these observations, we explore novel treatment schemes that prevent antifungal drug resistance development in C. auris and other pathogenic fungi.
format Online
Article
Text
id pubmed-9515916
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95159162022-09-28 S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire? Carolus, Hans Sofras, Dimitrios Sephton-Clark, Poppy Goossens, Louise Chen, Alicia Pierson, Siebe Romero, Celia Lobo Subotić, Ana Meis, Jacques F. Cuomo, Christina A. Van Dijck, Patrick Med Mycol Oral Presentations S2.5 RARE YEASTS, SEPTEMBER 21, 2022, 3:00 PM - 4:30 PM: Candida auris (C. auris) is a recently emerged human fungal pathogen of growing concern due to its ability to acquire extensive multidrug resistance (MDR) to all four antifungal drug classes. The unprecedented extent of MDR in C. auris, suggests accelerated resistance evolution, novel mechanisms of resistance, and/or potential fitness compensation. Despite being the first fungus to be officially considered an urgent antimicrobial resistance threat by the CDC (US), insights into the resistance mechanisms and evolutionary dynamics of C. auris are still scarce.  : By using high-throughput in vitro experimental evolution with various antifungal drugs, we have obtained a library of resistant strains from four different clades. Through both genome and targeted sequencing, we have discovered novel mutations, especially for polyene resistance, which indicate new mechanisms of resistance and fitness compensation. For the validation of mutations, we have optimized a recyclable CRISPR/Cas9 tool for C. auris based on the C. albicans HIS-FLP system.  : By mapping drug susceptibility responses of evolved strains across a library of several antifungals and repurposed drugs, we have discovered trends of cross-resistance and collateral sensitivity. Both phenomena have been extensively studied in tumors and bacteria but remain unexplored in fungi. In the light of these observations, we explore novel treatment schemes that prevent antifungal drug resistance development in C. auris and other pathogenic fungi. Oxford University Press 2022-09-20 /pmc/articles/PMC9515916/ http://dx.doi.org/10.1093/mmy/myac072.S2.5d Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Oral Presentations
Carolus, Hans
Sofras, Dimitrios
Sephton-Clark, Poppy
Goossens, Louise
Chen, Alicia
Pierson, Siebe
Romero, Celia Lobo
Subotić, Ana
Meis, Jacques F.
Cuomo, Christina A.
Van Dijck, Patrick
S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire?
title S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire?
title_full S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire?
title_fullStr S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire?
title_full_unstemmed S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire?
title_short S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire?
title_sort s2.5d exploring multidrug resistance, fitness compensation, and collateral sensitivity in candida auris : fight fire with fire?
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515916/
http://dx.doi.org/10.1093/mmy/myac072.S2.5d
work_keys_str_mv AT carolushans s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT sofrasdimitrios s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT sephtonclarkpoppy s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT goossenslouise s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT chenalicia s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT piersonsiebe s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT romerocelialobo s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT suboticana s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT meisjacquesf s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT cuomochristinaa s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire
AT vandijckpatrick s25dexploringmultidrugresistancefitnesscompensationandcollateralsensitivityincandidaaurisfightfirewithfire